Literature DB >> 10870574

The impact of lymph node metastases on the survival of breast cancer patients with ten or more positive lymph nodes.

A Tsuchiya1, M Kanno, R Abe.   

Abstract

To investigate the impact of the number of involved lymph nodes on survival, we retrospectively reviewed the data for 37 patients with breast cancer and metastases of ten or more lymph nodes who underwent treatment between 1987 and 1995. Based on the number of positive lymph nodes, the patients were allocated to one of three groups. The 5-year disease-free and overall survival rates for all patients were both 53.0%. The 7 patients with 26 or more positive nodes had significantly poorer survival than either the 19 patients with 10-15 nodes, or the 11 with 16-25 nodes, although there were no differences in survival related to the extent of node involvement as defined using the Japanese staging system. Patients with 50%-75% frequency of metastasis, defined as the positive nodes/total resected nodes, had significantly better survival than those with < 50% or > 75% frequency. These results indicate that the number of involved lymph nodes is related to survival and that 25 positive nodes is a cutoff point in breast cancer patients with ten or more positive lymph nodes.

Entities:  

Mesh:

Year:  1997        PMID: 10870574     DOI: 10.1007/bf02388136

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

Review 1.  High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer.

Authors:  D M Eddy
Journal:  J Clin Oncol       Date:  1992-04       Impact factor: 44.544

2.  Sounding board. Breast-cancer management: alternatives to radical mastectomy.

Authors:  B Fisher
Journal:  N Engl J Med       Date:  1979-08-09       Impact factor: 91.245

3.  Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors.

Authors:  T M Pisansky; J N Ingle; D J Schaid; A C Hass; J E Krook; J H Donohue; T E Witzig; L E Wold
Journal:  Cancer       Date:  1993-08-15       Impact factor: 6.860

4.  The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons.

Authors:  R E Wilson; W L Donegan; C Mettlin; N Natarajan; C R Smart; G P Murphy
Journal:  Surg Gynecol Obstet       Date:  1984-10

5.  The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.

Authors:  B Fisher; N Wolmark; M Bauer; C Redmond; M Gebhardt
Journal:  Surg Gynecol Obstet       Date:  1981-06

6.  Development and use of a natural history data base of breast cancer studies.

Authors:  T E Moon; S E Jones; G Bonadonna; P Valagussa; T Powles; A Buzdar; E Montague
Journal:  Am J Clin Oncol       Date:  1987-10       Impact factor: 2.339

7.  The general rules for clinical and pathological recording of breast cancer. Japanese Breast Cancer Society.

Authors: 
Journal:  Jpn J Surg       Date:  1989-09

Review 8.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1992-01-04       Impact factor: 79.321

9.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update.

Authors:  B Fisher; M Bauer; D L Wickerham; C K Redmond; E R Fisher; A B Cruz; R Foster; B Gardner; H Lerner; R Margolese
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

10.  The natural history of breast cancer with more than 10 positive nodes.

Authors:  M J Walker; M D Osborne; D C Young; S Schneebaum; G J La Valle; W B Farrar
Journal:  Am J Surg       Date:  1995-06       Impact factor: 2.565

View more
  4 in total

1.  Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years?

Authors:  Gul Basaran; Cabuk Devrim; Hale B Caglar; Bahadir Gulluoglu; Handan Kaya; Selcuk Seber; Taner Korkmaz; Ferhat Telli; Muharrem Kocak; Faysal Dane; Fulden P Yumuk; Serdar N Turhal
Journal:  Med Oncol       Date:  2011-09       Impact factor: 3.064

2.  Factors influencing the outcome of breast cancer patients with 10 or more metastasized axillary lymph nodes.

Authors:  Jun Sang Lee; Seung Il Kim; So Young Choi; Hyung Seok Park; Jong Seok Lee; Seho Park; Jaseung Koo; Byeong-Woo Park; Kyong Sik Lee
Journal:  Int J Clin Oncol       Date:  2011-03-01       Impact factor: 3.402

3.  The value of positive lymph nodes ratio combined with negative lymph node count in prediction of breast cancer survival.

Authors:  Jing Yang; Quanyi Long; Hongjiang Li; Qing Lv; Qiuwen Tan; Xiaoqin Yang
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

4.  The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer.

Authors:  Min He; Jia-Xin Zhang; Yi-Zhou Jiang; Ying-Le Chen; Hai-Yuan Yang; Li-Chen Tang; Zhi-Ming Shao; Gen-Hong Di
Journal:  Oncotarget       Date:  2017-07-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.